Parkinsons Disease

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

Parkinsons Disease

PARKINSONS DIS-US

ISSN / eISSN

2042-0080 / 2090-8083

Aims and Scope

Parkinson’s Disease is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the epidemiology, etiology, pathogenesis, genetics, cellular, molecular and neurophysiology, as well as the diagnosis and treatment of Parkinson’s disease.

Subject Area

CLINICAL NEUROLOGY

CiteScore

5.20

View Trend

CiteScore Ranking

Category	Quartile	Rank
Neuroscience - Neuroscience (miscellaneous)	Q1	#10/38
Neuroscience - Psychiatry and Mental Health	Q2	#163/531
Neuroscience - Neurology (clinical)	Q2	#135/373

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
CLINICAL NEUROLOGY - SCIE	Q2

H-index

Country/Area of Publication

UNITED STATES

Publisher

Hindawi Limited

Annual Article Volume

Open Access

YES

Contact

ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, ENGLAND, W1T 5HF

Popular journals in the same field
Recent articles

The Role of Muscle Strength in the Sit-to-Stand Task in Parkinson’s Disease: (2023) José Fidel Baizabal-Carvallo, Marlene Alonso-Juarez, Robert Fekete

Protective Role of AMPK against PINK1B9 Flies’ Neurodegeneration with Improved Mitochondrial Function: (2023) Guoliang Xiang, Xueyi Wen, Wenjing Wang, Tianchan Peng, Jiazhen Wang, Qinghua Li, Junfang Teng, Ying Cui

Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson’s Disease: (2023) Kristina Rosqvist, Per Odin

The Neuroprotective Effect of Isotetrandrine on Parkinson’s Disease via Anti-Inflammation and Antiapoptosis In Vitro and In Vivo: (2023) Ching-Hu Wu, Kun-Ling Lin, Cheng-Yu Long, Chien-Wei Feng

Levodopa Prescription Patterns in Patients with Advanced Parkinson’s Disease: A Japanese Database Analysis: (2023) Atsushi Takeda, Toru Baba, Jun Watanabe, Masahiko Nakayama, Hiroyuki Hozawa, Miwako Ishido

A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease: (2023) Zijuan Zhang, Ming Shi, Zhengmin Li, Yuan Ling, Luke Zhai, Ye Yuan, He Ma, Li Hao, Zhonghua Li, Zhenqiang Zhang, Christian Hölscher

Mercury and Parkinson’s Disease: Promising Leads, but Research Is Needed: (2023) E. Fuller Torrey, Wendy Simmons

Qualitative Analysis of Attitudes, Knowledge, and Interest in Research of People with Parkinson’s Disease and Their Care Partners Receiving Accessible Research Education: (2023) Maria E. Ramos, Suraj Pothineni, Liang Ni, Allison A. Bay, Todd Prusin, Madeleine E. Hackney

Supplementary Motor Area Activity Differs in Parkinson’s Disease with and without Freezing of Gait: (2023) J. Sebastian Marquez, Ronny P. Bartsch, Moritz Günther, S. M. Shafiul Hasan, Or Koren, Meir Plotnik, Ou Bai

Delivering Optimal Care to People with Cognitive Impairment in Parkinson’s Disease: A Qualitative Study of Patient, Caregiver, and Professional Perspectives: (2023) Jennifer S. Pigott, Nathan Davies, Elizabeth Chesterman, Joy Read, Danielle Nimmons, Kate Walters, Megan Armstrong, Anette Schrag

Verified Reviews

Note: Verified reviews are sourced from across review platforms and social media globally.

Half a month after submission, it will be reviewed. Two months later, it will be returned for major revisions. In one month, supplementary experiments will be conducted and returned. Minor revisions will be made in half a month, and it will be accepted one week after resubmission.

2022-07-29

View All Reviews

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now